Literature DB >> 23963300

Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome.

Erica F Andersen1, John C Carey2, Dawn L Earl3, Deyanira Corzo4, Michael Suttie5, Peter Hammond5, Sarah T South6.   

Abstract

Wolf-Hirschhorn syndrome (WHS) is a complex genetic disorder caused by the loss of genomic material from the short arm of chromosome 4. Genotype-phenotype correlation studies indicated that the loss of genes within 4p16.3 is necessary for expression of the core features of the phenotype. Within this region, haploinsufficiency of the genes WHSC1 and LETM1 is thought to be a major contributor to the pathogenesis of WHS. We present clinical findings for three patients with relatively small (<400 kb) de novo interstitial deletions that overlap WHSC1 and LETM1. 3D facial analysis was performed for two of these patients. Based on our findings, we propose that hemizygosity of WHSC1 and LETM1 is associated with a clinical phenotype characterized by growth deficiency, feeding difficulties, and motor and speech delays. The deletion of additional genes nearby WHSC1 and LETM1 does not result in a marked increase in the severity of clinical features, arguing against their haploinsufficiency. The absence of seizures and typical WHS craniofacial findings in our cohort suggest that deletion of distinct or additional 4p16.3 genes is necessary for expression of these features. Altogether, these results show that although loss-of-function for WHSC1 and/or LETM1 contributes to some of the features of WHS, deletion of additional genes is required for the full expression of the phenotype, providing further support that WHS is a contiguous gene deletion disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963300      PMCID: PMC3953918          DOI: 10.1038/ejhg.2013.192

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  47 in total

1.  Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map.

Authors:  G Van Buggenhout; C Melotte; B Dutta; G Froyen; P Van Hummelen; P Marynen; G Matthijs; T de Ravel; K Devriendt; J P Fryns; J R Vermeesch
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

2.  Diverse mutational mechanisms cause pathogenic subtelomeric rearrangements.

Authors:  Yue Luo; Karen E Hermetz; Jodi M Jackson; Jennifer G Mulle; Anne Dodd; Karen D Tsuchiya; Blake C Ballif; Lisa G Shaffer; Jannine D Cody; David H Ledbetter; Christa L Martin; M Katharine Rudd
Journal:  Hum Mol Genet       Date:  2011-07-04       Impact factor: 6.150

Review 3.  Histone methylation: a dynamic mark in health, disease and inheritance.

Authors:  Eric L Greer; Yang Shi
Journal:  Nat Rev Genet       Date:  2012-04-03       Impact factor: 53.242

4.  A microdeletion proximal of the critical deletion region is associated with mild Wolf-Hirschhorn syndrome.

Authors:  Femke Hannes; Peter Hammond; Oliver Quarrell; Jean-Pierre Fryns; Koenraad Devriendt; Joris R Vermeesch
Journal:  Am J Med Genet A       Date:  2012-03-21       Impact factor: 2.802

5.  Fine-grained facial phenotype-genotype analysis in Wolf-Hirschhorn syndrome.

Authors:  Peter Hammond; Femke Hannes; Michael Suttie; Koen Devriendt; Joris Robert Vermeesch; Francesca Faravelli; Francesca Forzano; Susan Parekh; Steve Williams; Dominic McMullan; Sarah T South; John C Carey; Oliver Quarrell
Journal:  Eur J Hum Genet       Date:  2011-07-27       Impact factor: 4.246

6.  Endoplasmic reticulum potassium-hydrogen exchanger and small conductance calcium-activated potassium channel activities are essential for ER calcium uptake in neurons and cardiomyocytes.

Authors:  Malle Kuum; Vladimir Veksler; Joanna Liiv; Renee Ventura-Clapier; Allen Kaasik
Journal:  J Cell Sci       Date:  2012-02-13       Impact factor: 5.285

7.  Characterizing the functional consequences of haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel cellular phenotypes in Wolf-Hirschhorn syndrome.

Authors:  Claudia Kerzendorfer; Femke Hannes; Rita Colnaghi; Iga Abramowicz; Gillian Carpenter; Joris Robert Vermeesch; Mark O'Driscoll
Journal:  Hum Mol Genet       Date:  2012-02-10       Impact factor: 6.150

8.  1.5Mb deletion of chromosome 4p16.3 associated with postnatal growth delay, psychomotor impairment, epilepsy, impulsive behavior and asynchronous skeletal development.

Authors:  D Misceo; T Barøy; J R Helle; O Braaten; M Fannemel; E Frengen
Journal:  Gene       Date:  2012-07-27       Impact factor: 3.688

9.  The histone methyltransferase MMSET regulates class switch recombination.

Authors:  Huadong Pei; Xiaosheng Wu; Tongzheng Liu; Kefei Yu; Diane F Jelinek; Zhenkun Lou
Journal:  J Immunol       Date:  2012-12-14       Impact factor: 5.422

10.  Growth hormone, gender and face shape in Prader-Willi syndrome.

Authors:  Mauren Abreu de Souza; Catherine McAllister; Michael Suttie; Concetta Perrotta; Teresa Mattina; Francesca Faravelli; Francesca Forzano; Anthony Holland; Peter Hammond
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

View more
  19 in total

Review 1.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

2.  Partial Monosomy 4p and Trisomy 12q due to a t(4;12)(p16.3;q24.31) Familial Translocation in Two Cousins.

Authors:  Tatiana Mozer Joaquim; Carlos H Paiva Grangeiro; Flávia Gaona de Oliveira Gennaro; Alexandra Galvão Gomes; Jeremy A Squire; Lucia R Martelli
Journal:  Mol Syndromol       Date:  2019-07-27

3.  Wolf-Hirschhorn Syndrome: Clinical and Genetic Data from a First Case Diagnosed in Central Africa.

Authors:  Sébastien Mbuyi-Musanzayi; Aimé Lumaka; Toni Lubala Kasole; Erick Kasamba Ilunga; Bienvenu Yogolelo Asani; Prosper Lukusa Tshilobo; Prosper Kalenga Muenze; Hervé Reychler; François Tshilombo Katombe; Koenraad Devriendt
Journal:  J Pediatr Genet       Date:  2017-03-07

4.  The catalytic domain of the histone methyltransferase NSD2/MMSET is required for the generation of B1 cells in mice.

Authors:  Marc-Werner Dobenecker; Jonas Marcello; Annette Becker; Eugene Rudensky; Natarajan V Bhanu; Thomas Carrol; Benjamin A Garcia; Rabinder Prinjha; Vyacheslav Yurchenko; Alexander Tarakhovsky
Journal:  FEBS Lett       Date:  2020-08-29       Impact factor: 4.124

5.  Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome.

Authors:  Thiago Corrêa; Maytza Mayndra; Cíntia B Santos-Rebouças
Journal:  Mol Neurobiol       Date:  2022-03-12       Impact factor: 5.590

Review 6.  Mitochondrial calcium exchange in physiology and disease.

Authors:  Joanne F Garbincius; John W Elrod
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

7.  Interstitial 287 kb deletion of 4p16.3 including FGFRL1 gene associated with language impairment and overgrowth.

Authors:  Eunice Matoso; Fabiana Ramos; José Ferrão; Luís M Pires; Alexandra Mascarenhas; Joana B Melo; Isabel M Carreira
Journal:  Mol Cytogenet       Date:  2014-12-09       Impact factor: 2.009

8.  Histone H3 lysine 36 methyltransferase Whsc1 promotes the association of Runx2 and p300 in the activation of bone-related genes.

Authors:  Yu Fei Lee; Keisuke Nimura; Wan Ning Lo; Kotaro Saga; Yasufumi Kaneda
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

9.  Severe short stature and Wolf-Hirschhorn syndrome: response to growth hormone in two cases without growth hormone deficiency.

Authors:  Devon E Austin; Alistair J Gunn; Craig A Jefferies
Journal:  Oxf Med Case Reports       Date:  2015-02-28

10.  LETM1 haploinsufficiency causes mitochondrial defects in cells from humans with Wolf-Hirschhorn syndrome: implications for dissecting the underlying pathomechanisms in this condition.

Authors:  Lesley Hart; Anita Rauch; Antony M Carr; Joris R Vermeesch; Mark O'Driscoll
Journal:  Dis Model Mech       Date:  2014-03-13       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.